SENZA.ST Stock - SenzaGen AB
Unlock GoAI Insights for SENZA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $57.70M | $49.87M | $41.77M | $15.42M | $7.96M |
| Gross Profit | $38.59M | $34.93M | $27.34M | $9.45M | $2.95M |
| Gross Margin | 66.9% | 70.0% | 65.4% | 61.3% | 37.1% |
| Operating Income | $-18,949,000 | $-14,740,000 | $-20,190,000 | $-31,533,000 | $-27,098,000 |
| Net Income | $-17,850,000 | $-22,097,000 | $-24,912,000 | $-31,346,000 | $-27,315,000 |
| Net Margin | -30.9% | -44.3% | -59.6% | -203.3% | -343.2% |
| EPS | $-0.65 | $-0.91 | $-1.03 | $-1.30 | $-1.28 |
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation and corrosion testing services. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. The company was incorporated in 2010 and is headquartered in Lund, Sweden.
Visit WebsiteEarnings History & Surprises
SENZA.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 5, 2025 | — | — | — | — |
Q2 2025 | May 14, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.16 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.08 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.30 | — | — |
Q2 2024 | May 3, 2024 | — | $-0.13 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.41 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.20 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.51 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.20 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.47 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.24 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.56 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.28 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.78 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.35 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.65 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.33 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.67 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.33 | — | — |
Latest News
Frequently Asked Questions about SENZA.ST
What is SENZA.ST's current stock price?
What is the analyst price target for SENZA.ST?
What sector is SenzaGen AB in?
What is SENZA.ST's market cap?
Does SENZA.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SENZA.ST for comparison